Cited by

• Peripheral neural targets in obesity.

  Page AJ, Symonds E, Peiris M, Blackshaw LA, Young RL. Page AJ, et al. Br J Pharmacol. 2012 Jul;166(5):1537-58. doi: 10.1111/j.1476-5381.2012.01951.x. Br J Pharmacol. 2012. PMID: 22432806 Free PMC article. Review.
• Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogue.

  Pan LC, Carpino PA, Lefker BA, Ragan JA, Toler SM, Pettersen JC, Nettleton DO, Ng O, Pirie CM, Chidsey-Frink K, Lu B, Nickerson DF, Tess DA, Mullins MA, MacLean DB, DaSilva-Jardine PA, Thompson DD. Pan LC, et al. Endocrine. 2001 Feb;14(1):121-32. doi: 10.1385/endo:14:1:121. Endocrine. 2001. PMID: 11322494
• Rapid and opposite effects of dexamethasone on in vivo and in vitro hypothalamic somatostatin release.

  Estupina C, Belmar J, Tapia-Arancibia L, Astier H, Arancibia S. Estupina C, et al. Exp Brain Res. 1997 Feb;113(2):337-42. doi: 10.1007/BF02450331. Exp Brain Res. 1997. PMID: 9063719
• Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis.

  Stojiljković AS, Čupić Ž, Maćešić S, Ivanović-Šašić A, Kolar-Anić L. Stojiljković AS, et al. Front Endocrinol (Lausanne). 2022 Oct 5;13:976323. doi: 10.3389/fendo.2022.976323. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36277700 Free PMC article.
• Higher molecular weight forms of immunoreactive somatostatin in mouse hypothalamic extracts: evidence of processing in vitro.

  Lauber M, Camier M, Cohen P. Lauber M, et al. Proc Natl Acad Sci U S A. 1979 Nov;76(11):6004-8. doi: 10.1073/pnas.76.11.6004. Proc Natl Acad Sci U S A. 1979. PMID: 42908 Free PMC article.